PD-L1 Positive

7 registered clinical trials studyying PD-L1 Positive — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Sintilimab Combined With Chemotherapy for Adjuvant Treatment of Mucosal Melanoma After Surgery NCT07400302	The First Hospital of Jilin University	Phase 2
Not Yet Recruiting	Sac-TMT Combined With Toripalimab for First-line Treatment of PD-L1 Positive a/mTNBC NCT07244874	Tianjin Medical University Cancer Institute and Hospital	Phase 2
Not Yet Recruiting	Sacituzumab Tirumotecan Plus Tagitanlimab in Previously Treated Locally Advanced or Metastatic Triple Negative NCT07153965	Tianjin Medical University Cancer Institute and Hospital	Phase 2
Not Yet Recruiting	A Clinical Study on the Efficacy and Safety of the Combination of Limertinib and Bevacizumab Versus Limertinib NCT06982924	Shanghai Chest Hospital	Phase 2
Not Yet Recruiting	Establishment of Precision Targeted Therapy Strategies for Advanced Gastric Cancer Based on Novel Molecular Su NCT06881017	China Medical University, China	Phase 2
Active Not Recruiting	Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab NCT05382286	Gilead Sciences	Phase 3
Active Not Recruiting	CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or NCT02955290	Roswell Park Cancer Institute	Phase 1 / Phase 2